ADIL vs FDX · $6.0M cap vs P/E 18, rev $94.72B
Adial Pharmaceuticals Inc (ADIL) versus FedEx Corporation (FDX) — a side-by-side from cached financials, not a winner call.
Adial Pharmaceuticals Inc (ADIL) is a biotechnology company listed on NASDAQ.
FedEx Corporation (FDX) is a integrated freight & logistics company listed on US.
ADIL does not have a complete income-statement cache yet.
Latest reported FDX revenue for 2026-05-31 was $94.72B. Net income was $4.43B. Revenue was up 7.7% from 2025-05-31 to 2026-05-31. FDX currently screens at market cap $78.98B and trailing P/E 17.7.
ADIL currently screens at market cap $6.0M. FDX currently screens at market cap $78.98B and trailing P/E 17.7.
Not investment advice. Open the ADIL and FDX stock pages for the full models.
Not investment advice.